Cannasoul is an Israeli cannabis drug-discovery company developing therapeutics derived from natural compounds. Cannasoul's proprietary analytical platform, data-driven approach, knowhow, and clinical trial framework support active compound identification and development, from botanical extract through clinical approved formulation. Cannasoul has analyzed over 100 cannabinoids and 100 terpenes. The company's subsidiaries include MyPlant Bio, Psyga Bio, Nidra Logic, and CaVnox.